DAFTAR PUSTAKA

Adham, M., Kurniawan, A.N., Muhtadi, A.I., Roezin, A., Hermani, B.,
Gondhowiardjo, S et al. 2012. Nasopharungeal Carcinoma in Indonesia:
epidemiology, incidence, sign and symptoms at presentation. Chin J
Cancer. 31(4):185-196.
Ariwibowo, H. 2013. Faktor Risiko Karsinoma Nasofaring. Cermin Dunia
Kedokteran. 40(5):348-351.
Beavon, I.R.G. 1999. Regulation of E-cadherin: does hypoxia initiate the
metastatic cascade? J Clin Pathol Mol Pathol. 52:179-188.
Bensouda, Y., Kaikani, W., Ahbeddou, N., Rahhali, R., Jabri, M., Mrabti, H et al.
2011. Treatment for metastatic nasopharyngeal carcinoma. European
Annals of Otorhinolaryngology, Head and Neck diseases. 128: 79-85.
Brennan, B. 2006. Nasopharyngeal carcinoma. Orphanet Journal of Rare
Diseases. 1(23):1-5.
Cao, X., He, L.R., Xie, F.Y., Chen, Y.F., Wen, Z.S. 2011. Factors determining
the survival of nasopharyngeal carcinoma with lung metastasis alone: does
combined modality treatment benefit? BMC Cancer. 11(370):1-9
Chan, A.T.C., Teo, P.M.L., Johnson, P.J. 2002. Nasopharyngeal Carcinoma:
Review. Annals of Otolaryngology. 13:1007-1015.
Chen, C.H., Shiu, L.Y., Su, L.J., Huang, C.Y.F., Huang, S.C., Huang, C.C et al.
2012. FLJ10540 is associated with tumor progression in nasopharyngeal
carcinomas and contributes to nasopharyngeal cell proliferation, and
metastasis via osteopontin/CD44 pathway. Journal of Translational
Medicine. 10(93):1-12.
Chien, C.R., Chen, S. W., Hsieh, C.Y., Liang, J.A., Yang, S.N, Huang, C.Y et
al. 2001. Retrospective comparison of the AJCC 5th edition classification
for nasopharyngeal carcinoma with the AJCC 4th edition: an experience in
Taiwan. Jpn J Clin Oncol. 2001. 31(8):363-9.
Chong, H.S., Yunus, M.R.H., Lum, C.L. 2011. Mandibular Metastasis from
Nasopharyngeal Carcinoma. Philipp J Otolaryngol Head Neck Surg. 26
(2):18-20
Christofori, G dan Semb, H. 1999. The role of the cell-adhesion molecule Ecadherin as a tumour-suppressor gene. Trends in Biochemical Sciences.
24(2):73-76.
Corry, J., Fisher, R., Rischin, D., Peters, A.L.J. 2006. Relapse Patterns In Who
2/3 Nasopharyngeal Cancer: Is There A Difference Between Ethnic Asian
Vs. Non-Asian Patients? Int. J. Radiation Oncology Biol. Phys. 64(1)63
71

48

49

Dahlan, M.P. 2011. Analisis Regresi Logistik. In: Statistik Untuk Kedokteran
dan Kesehatan. 5th ed. Salemba Medika. Jakarta. p.197-208.
del Muro, X.G., Torregrosa, A., Munoz, J., Castellsague, X., Condom, E., Vigues,
F et al. 2000. Prognostic value of the expression of E-cadherin and b
catenin in bladder cancer. European Journal of Cancer. 36:357-362
Fendri, A., Khabir, A., Guiga, B.H., Boudawara, T.H., Ghorbel, A., Daoud, J et
al. 2008. Overexpression of COX-2 and LMP1 are correlated with lymph
node in Tunisian NPC patients. Oral Oncology. 44, 710 715
Hajra, K.H. dan Fearon, E.R. 2002. Cadherin And Catenin Alterations In Human
Cancer. Genes, Chromosomes & Cancer. 34:255268
Howell, G.M.S., and Grandis, J.R. 2005. Molecular Mediators of Metastasis In
Head and Neck Squamous Cell Carcinoma. Head Neck. 27:710-717.
Huang, D.P. 1999. Aetiologi Factor and Pathogenesis. In Van Hasselt, C.A, Gibb,
A.G. editor. Nasopharyngeal Carcinoma. 2nd ed. The Chinese University
Press. Hongkong. p.31-36
Huang, G.W., Mo, W.N., Kuang, G.Q., Nong, H.T., Wei, M.Y., Sunagawa, M et
al. 2001. Expression of p16, nm23-H1, E-cadherin, and CD44 Gene
Products and Their Significance in Nasopharyngeal Carcinoma.
Laryngoscope. 111:1465-1471.
Jeyakumar, A., Brickman, T.M., Jeyakumar, A., Doerr, T. 2006. Review of
Nasopharyngeal Carcinoma. Ear Nose Throat J. 85(3):168-173
Jones, J.L., Royall, J.E., Walker, R.A. 1996. E-cadherin relates to EGFR
expression and lymph node metastasis in primary breast carcinoma.
British Journal of Cancer. 74:1237-124.
Khademi, B., Mahmoodi, J., Omidvari, S., Mohammadianpanah, M. 2006.
Treatment Results of Nasopharyngeal Carcinoma: A 15-Year Single
Institutional Experience. Journal of the Egyptian Nat. Cancer Inst.
18(2):147-155
Kim, C.H., Kim, J.H., Kahng, H., Choi, E.C. 2007. Change of E Cadherin by
Hepatocyte Growth Factor and Effects on the Prognosis of
Hypopharyngeal Carcinoma. Ann Surg Oncol. 14(5):1565-1574.
Kurniawan, A.N., Kodariah, R., Elisabeth, M., Roezin, A., Gondhowiardjo, S.
2002.
Evaluation of EBV-LMPI as prognostic indicator of
nasopharyngeal carcinoma in Indonesian patients. Med J Indones.
1(2):81-86.
Li, J.J., Zhang, G.H., Yang, X.M., Li, S.S., Liu, X., Yang, Q.T et al. 2012.
Reduced E-cadherin expression is associated with lymph node metastases
in laryngeal squamous cell carcinoma Auris Nasus Larynx. 39:186-192.
Masterson, J and ODea, S. 2007. Posttranslational Truncation of E-Cadherin and
Significance for Tumour Progression. Cells Tissues Organs. 185:175-179.

50

Moreno, P.M., Jamora, C., Fuchs, E. 2003. Sticky Business: Orchestrating

Cellular Review Signals at Adherens Junctions. Cell. 112:535548.
Niemhom, S., Kitazawa, S., Kitazawa, R., Maeda, S., Leopairat., J. 2008.
Hypermethylation of epithelial-cadherin gene promoter is associated with
Epstein-Barr virus in nasopharyngeal carcinoma. Cancer Detection and
Prevention. 32:127-134.
Ocheni, S., Olusina, D.B., Oyekunle, A.A., Ibegbulam, O.G., Krger, N., Bacher,
U et al. 2010. EBV-Associated Malignancies. The Open Infectious
Diseases Journal. 4:101-112.
Pua, K.C., Khoo, A.S.B., Yap, Y.Y., Subramaniam, S.K., Ong, C.A., Krishnan,
G.G et al. 2008. Nasopharyngeal Carcinoma Database. Med J Malaysia.
63:59-62.
Ramburan, A and Govender, D. 2002. Cadherins and catenins in pathology.
Current Diagnostic Pathology. 8:305-317.
Razak, A.R.A., Siu, L.L., Liu, F.F., Ito, E., OSullivan, B., Chan, K. 2010.
Nasopharyngeal carcinoma: The next challenges. European Journal of
Cancer. 4 6:1967-1978.
Roezen, A dan Adham, M. 2011. Karsinoma Nasofaring. In: Buku Ajar Ilmu
Kesehatan Telinga Hidung Tenggorok Kepala dan Leher. 5th ed. Balai
Penerbit Fakultas Kedokteran Indonesia. Jakarta. p. 182-187.
Ruiz, H.G., Rios, M.J, Campora, R.G., de Miguel, M., Carmona, M.I., Moreno,
A.M et al. 2011. The cadherincatenin complex in nasopharyngeal
carcinoma. Eur Arch Otorhinolaryngol. 268:13351341
Schmalhofer, O., Brabletz, S., Brabletz, T. 2009. E-cadherin, -catenin, and ZEB1
in malignant progression of cancer. Cancer Metastasis Rev. 28(1-2):151166
Sela, G.B., Kuten, A., Minkov, I., Ari, E.G., Izhak, O.B. 2004. Prevalence and
relevance of EBV latency in nasopharyngeal carcinoma in Israel. J Clin
Pathol. 57:290293
Semb, H., and Christofori, G. 1998. The Tumor-Suppressor Function of ECadherin. Am J Hum Genet. 63:1588-1593.
Sharma, T.D., Singh, T., Laishram, R.S., Sharma, L.D.C., Sunita, A.K., Imchen,
T. 2011. Nasopharyngeal Carcinoma - a Clinico-pathological Study in a
Regional Cancer Centre of Northeastern India. Asian Pacific J Cancer
Prev. 12:1583-1587
Shnayder, Y., Kuriakose, A., Yee, H., Chen, F.A., DeLacure, M.D., Xue, X.N et
al. 2001. Adhesion Molecules as Prognostic Factors in Nasopharyngeal
Carcinoma. Laryngoscope. 111:1842-1846.

51

Spano, J.P., Busson, P., Atlan, D., Bourhis, J.,Pignon, J.P., Esteban, C et al. 2003.
Nasopharyngeal carcinomas: an update. European Journal of Cancer.
39:2121-2135.
Tamori. A.T., Yoshizaki, T., Miwa, T., Furukawa, M. 2000. Clinical
evaluation of staging system for nasopharyngeal carcinoma: comparison of
fourth and fifth editions of UICC TNM classification. Ann Otol Rhinol
Laryngol. 109(12 Pt 1):1125-9.
Titcomb, C.P. 2001. High Incidence of Nasopharyngeal Carcinoma in Asia. J
Insur Med. 33:235-238.
Traub, N.R. 2002. EpsteinBarr virus in the pathogenesis of NPC. Seminars in
Cancer Biology. 12(6):431-441.
Tsai, C.L., Li, H.P., Lu, Y.J., Hsueh, C., Liang, Y., Chen, C.L. 2006. Activation
of DNA Methyltransferase 1 by EBV LMP1 Involves c-Jun NH2-Terminal
Kinase Signaling. Cancer Res. 66:11668-11676
Tsao, S.W., Liu, Y., Wang, X., Yuen, P.W., Leung, S.Y., Yuen, S.T et al. 2003.
The association of E-cadherin expression and the methylation status of the
E-cadherin gene in nasopharyngeal carcinoma cells. European Journal of
Cancer. 39:524-531.
Wei, W.I. 2006. Nasopharyngeal Cancer. In: Baley BJ & Johnson JT, Head &
Neck Surgery-Otolaryngology. 4th edition. Lippincott Williams & Wilkins.
p.1658-1671.
Wei, W.I. and Kwong, D.L.W. 2010. Current Management Strategy of
Nasopharyngeal
Carcinoma.
Clinical
and
Experimental
Otorhinolaryngology. 3(1):1-12
Xie, L.Q., Bian, L.J., Li, Z., Li, Y., Li, Z.X., Li, B. 2010. Altered Expression of
E-cadherin by Hepatocyte Growth Factor and Effect on the Prognosis of
Nasopharyngeal Carcinoma. Ann Surg Oncol. 17:1927-1936.
Xu, L., Jiang, Y., Zheng, J., Xie, G., Li, J., Shi, L et al. 2013. Aberrant expression
of -catenin and E-cadherin is correlated with poor prognosis of
nasopharyngeal cancer. Hum Pathol. 44:1357-1364.
Yilmaz, M., Christofori, G., Lehembre, F. 2007. Distinct mechanisms of tumor
invasion and metastasis. Trends in Molecular Medicine. 13(12):535-541.
Yip, W.K and Seow, H.F. 2012. Activation of phosphatidylinositol 3-kinase/Akt
signaling by EGF downregulates membranous E-cadherin and b-catenin
and enhances invasion in nasopharyngeal carcinoma cells. Cancer Letters.
318:162-172
Yu, L., Lu, J., Zhang, B., Liu, X., Wang, L., Li, S.Y et al. 2013. miR-26a inhibits
invasion and metastasis of nasopharyngealcancer by targeting EZH2.
Oncology Letters. 1234-12288.

52

Zhang, H., Liu, J., Yue, D., Gao, L., Wang, D., Zhang, H. 2013. Clinical
significance of E-cadherin, -catenin, vimentin and S100A4 expression in
completely resected squamous cell lung carcinoma. J Clin Pathol.
66:937-945
Zhao, Y., Wang, Y., Zeng, S., Hu, X. 2012. LMP1 expression is positively
associated with metastasis of nasopharyngeal carcinoma: evidence from a
meta-analysis. J Clin Pathol. 65:41-45.